Sign in

CIK 0001806310

  • Non-accelerated filer
  • Smaller reporting company

Taysha Gene Therapies, Inc.

Sign in to watch
Ticker
TSHA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
843199512
Phone
+1 214-612-0000
Business address
3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-26 Nolan Sean P. Chief Executive Officer Sale −41,312 $4.61 $190K 2,908,257
2026-01-23 Nolan Sean P. Chief Executive Officer Sale −136,789 $4.75 $650K 2,949,569
2026-01-12 Nolan Sean P. Chief Executive Officer Grant or award +1,008,000 3,086,358
2026-01-12 Nolan Sean P. Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +648,000 648,000
2025-01-02 Nolan Sean P. Chief Executive Officer Grant or award +892,500 2,078,358
2025-01-02 Nolan Sean P. Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +892,500 892,500
2024-01-02 Nolan Sean P. Chief Executive Officer Grant or award +1,184,688 1,185,858
2024-01-02 Nolan Sean P. Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +1,184,688 1,184,688
2023-12-14 Nolan Sean P. Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +466,550 466,550
2023-08-16 Nolan Sean P. Chief Executive Officer Purchase +444,444 $0.90 $400K 1,535,545
2022-12-30 Nolan Sean P. Chief Executive Officer Grant or award · Stock Option (right to buy) +1,106,131 1,106,131
2022-06-17 Nolan Sean P. Director Grant or award · Stock Option (right to buy) +15,500 15,500
2021-06-17 Nolan Sean P. Director Grant or award · Stock Option (right to buy) +15,500 15,500
2021-05-20 Nolan Sean P. Director Purchase +1,170 $22.35 $26K 1,170
2020-09-28 Nolan Sean P. Director Conversion +1,089,500 1,089,500
2020-09-28 Nolan Sean P. Director Conversion +1,601 1,091,101
2020-09-28 Nolan Sean P. Director Conversion · Series A Preferred Stock −1,000,000 0
2020-09-28 Nolan Sean P. Director Conversion · Series B Preferred Stock −1,470 0
2020-09-23 Nolan Sean P. Director Grant or award · Stock Option (right to buy) +31,000 31,000

Page 1 of 1 · 19 trades